ImmunoPrecise Antibodies Ltd's (CVE:IPA) president and chief executive Jennifer Bath caught up with Proactive Investors at the Spring Investor Summit 2019 in New York City.
Operating from their laboratory facilities at the Vancouver Island Technology Park in Victoria, British Columbia … ImmunoPrecise is an 'end-to-end' provider for accelerated antibody research and discovery.
Price: $0.65
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ImmunoPrecise Antibodies Ltd named herein, including the promotion by the Company of ImmunoPrecise Antibodies Ltd in any Content on the Site,...
FOR OUR FULL DISCLAIMER CLICK HERE
Great Bear Resources (CVE: GBR) President and CEO Chris Taylor joined Steve Darling from Proactive Vancouver to discuss their latest assay results from the drill program on the Dixie Project in Red Lake. Taylor discusser the results from the Hinge and Dixie Limb zones and also gave...
Mining
Prev article
